-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R9ej9JFIcSk7lJJlU8BJAFmFKC+MUrzgdBDf1X+8/9Lk8OqiBQUVZFRgRu54dg+d 5xEMwGriTaPHRA+enXA1Fg== 0000950153-02-000906.txt : 20020510 0000950153-02-000906.hdr.sgml : 20020510 ACCESSION NUMBER: 0000950153-02-000906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20020510 FILED AS OF DATE: 20020510 COMPANY DATA: COMPANY CONFORMED NAME: RADLICK PHIL CENTRAL INDEX KEY: 0001162524 DIRECTOR FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 9252494000 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIPID SCIENCES INC/ CENTRAL INDEX KEY: 0000071478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 430433090 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 02641497 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 925-249-4000 MAIL ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 FORMER COMPANY: FORMER CONFORMED NAME: NZ CORP DATE OF NAME CHANGE: 20000810 FORMER COMPANY: FORMER CONFORMED NAME: NEW MEXICO & ARIZONA LAND CO DATE OF NAME CHANGE: 19920703 4 1 p66594f2e4.htm FORM 4 - PHIL RADLICK e4
 

         
FORM 4
 
(BOX) Check this box if no longer
subject to Section 16. Form 4 or
Form 5 obligations may continue.
See Instruction 1(b).
(Print or type responses)		   U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
 
 
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 		 
OMB APPROVAL

 
OMB Number: 3235-0287
Expires: December 31, 2001
Estimated average burden
hours per response. . . . .0.5

1.   Name and Address of Reporting Person*

         
Radlick   Phil    
(Last)   (First)   (Middle)

c/o Lipid Sciences, Inc.
7068 Koll Center Parkway, Suite 401

(Street)
         
Pleasanton,   California   94566
(City)   (State)   (Zip)

2.   Issuer Name and Ticker or Trading Symbol
 
    Lipid Sciences, Inc. (LIPD)

3.   I.R.S. or Social Security Number of Reporting Person (Voluntary)
 
 
 

4.   Statement for Month/Year
 
    May 2002

5.   If Amendment, Date of Original (Month/Year)
 
     

6.   Relationship of Reporting Person to Issuer (Check all applicable)

             
(XBOX)   Director   (BOX )   10% Owner
             
(X)   Officer (give title below)   (BOX )   Other (specify below)

President and Chief Executive Officer

7.   Individual or Joint/Group Filing (Check Applicable Line)
 
    (X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person

Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

                                     
1. Title of Security   2. Trans-   3. Trans-   4. Securities Acquired (A)   5. Amount of   6. Ownership   7. Nature of
(Instr. 3)   action   action   or Disposed of (D)   Securities   Form:   Indirect
    Date   Code   (Instr. 3, 4 and 5)   Beneficially   Direct   Bene-
        (Instr. 8)       Owned at   (D) or   ficial
    (Month/  
 
  End of   Indirect   Owner-
    Day/               (A) or       Month   (I)   ship
    Year)   Code   V   Amount   (D)   Price   (Instr. 3 and 4)   (Instr. 4)   (Instr. 4)
Common Stock   5/02/2002   P       200   A   $5.16   200   D    
                                     
                                     
                                     
     
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.    
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).   (Over)

 

         
FORM 4 (continued)   Table II — Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) 		   
                                                         
1. Title of Derivative Security   2.Conver-   3.Trans-   4. Trans-   5. Number of Deriv-   6. Date Exerc-   7. Title and   8.Price   9. Number   10. Owner-   11. Nature
(Instr. 3)   sion or   action   action   ative Securities Ac-   isable and   Amount of   of   of deriv-   ship   of
    Exercise   Date   Code   quired (A) or Dis-   Expiration   Underlying   Deriv-   ative   Form of   Indirect
    Price of       (Instr. 8)   posed of (D)   Date   Securities   ative   Secur-   Deriv-   Benefi-
    Deriv-   (Month/       (Instr. 3, 4 and 5)   (Month/Day/   (Instr. 3 and 4)   Secur-   ities   ative   cial
    ative   Day/           Year)       ity   Bene-   Security   Owner-
    Security   Year)                   (Instr. 5)   ficially   Direct   ship
                                Owned   (D) or   (Instr. 4)
                                at End   Indirect    
                                of   (I)    
                                Month   (Instr. 4)    
                                (Instr. 4)        
           
 
 
 
               
                            Date   Expira-       Amount                
                            Exer-   tion       or                
            Code   V   (A)   (D)   cisable   Date   Title   Number                
                                        of Shares                
                                                         
                                                         
                                                         

Explanation of Responses:

             
**   Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18. U.S.C. 1001 and 15 U.S.C. 78ff(a).		    
 
/s/ Phil Radlick		    
 
5/10/02
       
 
        ** Signature of Reporting Person   Date
     
Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond
unless the form displays a currently valid OMB number.

Page 2 GRAPHIC 3 p66594f2box.gif GRAPHIC begin 644 p66594f2box.gif M1TE&.#EA#``,`/?^``````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H* M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9 M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*" M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1 MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYRGI^?GZ"@ MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^ MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)RWM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ M^OO[^_S\_/W]_?[^_O___R'Y!`$``/X`+``````,``P`!P@Z`/\)'$APX)L? M"!,J_/<#F;B'$!\:8"BNX,`#%"T*Q/BCHD:.'BV"U/AOY,>,)SN2Y&C@@,N7 &+@$$!``[ ` end GRAPHIC 4 p66594f2xbox.gif GRAPHIC begin 644 p66594f2xbox.gif M1TE&.#EA#``,`/?^``````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H* M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9 M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*" M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1 MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYRGI^?GZ"@ MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^ MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)RWM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ M^OO[^_S\_/W]_?[^_O___R'Y!`$``/X`+``````,``P`!PA>`/]%8T:PH,%_ M&0`H7,@0(3UF_R)&C*8N`T)P"O1(1"4@F$6+UB@0^H=*P2V$*/]94\!$P$F4 J%B/^`1!%XL>('#-EC'BSY,F0(S]& -----END PRIVACY-ENHANCED MESSAGE-----